CASI Pharmaceuticals Inc (NASDAQ:CASI)

7.00
Delayed Data
As of Apr 23
 +0.15 / +2.19%
Today’s Change
0.91
Today|||52-Week Range
7.61
+115.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-26.2M-7.2M-9.5M-10.8M
 
 
 
 
 
Depreciation48.2K68.4K66.5K117.8K
 
 
 
 
 
Total Other Cash Flow21.9M1.6M3.0M677.8K
 
 
 
 
 
Funds From Operations-4.3M-5.5M-6.4M-10.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-273.7K-36.0K-348.0K-3.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.0M-5.5M-6.0M-6.4M
 
 
 
 
 
 
InvestingCapital Expenditures-231.8K-25.4K-223.2K-934.7K
 
 
 
 
 
Fixed Asset Disposal----158.4K0.00
 
 
Other Investing - Uses-234.5K0.000.000.00
 
 
Net Cash Flow Investing-466.3K-25.4K-64.8K-934.7K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00--0.000.00--
Long Term Debt Reduction0.00--0.000.00--
Net Proceeds Stock Sale0.000.0028.0M23.7M
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends------0.00--
Cash Dividends Paid - Total------0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing0.000.0028.0M23.7M
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-4.5M-5.5M22.0M16.4M